Biologically active molecules that reduce polyglutamine aggregation and toxicity

By Desai Urvee A.   Pallos Judit   Ma Aye Aye K.   Stockwell Brent R.   Thompson Leslie Michels   Marsh J. Lawrence   Diamond Marc I.  

Human Molecular Genetics, Vol. 15, Iss. 13, 2006-07 ,pp. : 2114-2124

Oxford University Press

Access to resources Recommend Favorite

Rethinking Genotype and Phenotype Correlations in Polyglutamine Expansion Disorders

By Andrew Susan E.  

Human Molecular Genetics, Vol. 6, Iss. 12, 1997-11 ,pp. : 2005-2010

Oxford University Press

Access to resources Recommend Favorite

Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro

By Perez M.K.  

Human Molecular Genetics, Vol. 8, Iss. 4, 1999-04 ,pp. : 673-682

Oxford University Press

Access to resources Recommend Favorite

Inactivation of Drosophila Apaf-1 related killer suppresses formation of polyglutamine aggregates and blocks polyglutamine pathogenesis

By Sang Tzu-Kang  

Human Molecular Genetics, Vol. 14, Iss. 3, 2005-02 ,pp. : 357-372

Oxford University Press

Access to resources Recommend Favorite

Suppression of polyglutamine-induced protein aggregation in Caenorhabditis elegans by torsin proteins

By Caldwell G.A.   Cao S.   Sexton E.G.   Gelwix C.C.   Bevel J.P.   Caldwell K.A.  

Human Molecular Genetics, Vol. 12, Iss. 3, 2003-02 ,pp. : 307-319

Oxford University Press

Access to resources Recommend Favorite